IFNG and metabolic dysfunction-associated steatohepatitis: Collectively, both NASH human patient samples and NASH mouse models support the hypothesis that Th1 accelerates the initiation and progression of NASH, which may be due to the secretion of cytokines, such as IFN-γ and TNF-α.